/Companies

Vcreate

1 known investors

Find your way into Vcreate

Sign up to see every warm intro you have to Vcreate

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vcreate team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vcreate uses machine learning and single-cell sequencing screening assays to engineer human T-cell receptors (TCRs) for TCR-based therapies that target disease-specific antigens, including rare cancer mutations. Its platform screens hundreds of millions of TCR-antigen interactions to design receptors that activate against targets inside cells that are otherwise difficult to drug.

Founders & leadership

EFEthan Fast
Ethan FastCo-Founder and CTOEthan Fast holds a PhD in Computer Science from Stanford with research spanning human-computer interaction, machine learning, and programming languages. He has focused on immunology and machine learning applications, including TCR-antigen interaction prediction and MHC antigen presentation modeling, and is founder of Vcreate, which engineers T-cell receptors for cancer and other diseases.

Investors · 1

Founder mafia

2 people who came through Vcreate went on to found or lead other companies.

Frequently asked questions

What does Vcreate do?
Vcreate uses machine learning and single-cell sequencing screening assays to engineer human T-cell receptors (TCRs) for TCR-based therapies that target disease-specific antigens, including rare cancer mutations. Its platform screens hundreds of millions of TCR-antigen interactions to design receptors that activate against targets inside cells that are otherwise difficult to drug.
Who founded Vcreate?
Vcreate was founded by Ethan Fast.
Who are Vcreate's investors?
Vcreate's investors include Fifty Years.